TNF and inflammatory bowel disease: The efficacy of anti-TNF therapy in patients with IBD can be predicted using a variety of factors from both clinical (gender, patient factors, age, weight, disease duration, phenotype, smoking status, and medical comorbidities) and experimental (immunological markers, genetic markers, microbiome analysis, endoscopic evaluation, and serological markers) perspectives using invasive or noninvasive biological samples [8].